A Retrospective Cohort Study on the Risk of Serious Infections in Rheumatoid Arthritis Patients Receiving Tocilizumab

Conditions:   Infection;   Rheumatoid Arthritis Interventions:   Drug: Tocilizumab;   Drug: Tumor Necrosis Factor Inhibitor (etanercept, infliximab, adalimumab, and golimumab) Sponsors:   Sungkyunkwan University;   Ministry of Food and Drug Safety, Korea Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials